Table 3.

- Comparison between low dose and standard dose Alteplase treated acute ischemic stroke patients regarding their outcome of treatment assessed by modified rankin scale (mRS) at 3 months and prevalence of deaths.

Items	Low dose (n=40)	Standard dose (n=40)	Total (n=80)	x2	P -value
Outcome
Favorable	27 (67.5)	25 (62.5)	52 (65.0)	0.23	0.631
Death
In hospital	1 (2.5)	1 (2.5)	2 (2.5)	--	---
Within 3 months	2 (0.5)	1 (2.5)	3 (3.8)	0.35	0.556
Overall deaths	3 (7.5)	2 (5.0)	5 (6.3)	0.21	0.644

Values are presented as number and percentage (%). Favorable outcome: mRS from 0-2